18 - Induction of Early Onset Cardiovascular Disease by Methamphetamine

Session Chair(s)

• Kevin Murnane

  Louisiana State University Health Sciences Center – Shreveport

• Md. Shenuarin Bhuiyan

  Speaker
  Louisiana State University Health Sciences Center

Amphetamine-type stimulants are the most widely used class of illicit drugs in the world after cannabinoids, and there is a growing epidemic in illicit methamphetamine use. Methamphetamine can have adverse and potentially fatal effects on arteries and blood vessels, including elevated blood pressure, acute vasospasm, and atherosclerotic cardiovascular disease, and methamphetamine induces structural and electrical remodeling of cardiac tissue. This symposium will present human and animal studies regarding the impact of methamphetamine on the cardiovascular system, and discuss the findings that individuals exposed to methamphetamine present with early onset cardiovascular disease.

Presentations:

• 11:00 AM – 11:05 AM

  Introduction
• 11:05 AM – 11:30 AM

  Mitochondrial Dysfunction in Methamphetamine Associated Cardiomyopathy
  

  Speaker: Md. Shenuarin Bhuiyan – Louisiana State University Health Sciences Center
• 11:30 AM – 11:55 AM

  Gender Differences in the Cardiovascular Toxicity of Methamphetamine
  

  Speaker: Ralph Shohet – University of Hawaii
• 11:55 AM – 12:20 PM

  Molecular Mechanisms of Methamphetamine Induced Sudden Cardiac Death and Experimental Therapeutics.
  

  Speaker: Paari Dominic – LSU HEALTH SHREVEPORT
• 12:20 PM – 12:30 PM

  Methamphetamine-Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long-Term Self-Administration in Rats
  

  Presenting Author: Madison McGraw – University of Arkansas for Medical Sciences